These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24026514)

  • 1. Introduction of a new critical p value correction method for statistical significance analysis of metabonomics data.
    Wang B; Shi Z; Weber GF; Kennedy MA
    Anal Bioanal Chem; 2013 Oct; 405(26):8419-29. PubMed ID: 24026514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies in adjusting for multiple comparisons: A primer for pediatric surgeons.
    Staffa SJ; Zurakowski D
    J Pediatr Surg; 2020 Sep; 55(9):1699-1705. PubMed ID: 32029234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical significance analysis of nuclear magnetic resonance-based metabonomics data.
    Goodpaster AM; Romick-Rosendale LE; Kennedy MA
    Anal Biochem; 2010 Jun; 401(1):134-43. PubMed ID: 20159006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic Spectroscopic Data Categorization by Clustering Analysis (ASCLAN): A Data-Driven Approach for Distinguishing Discriminatory Metabolites for Phenotypic Subclasses.
    Zou X; Holmes E; Nicholson JK; Loo RL
    Anal Chem; 2016 Jun; 88(11):5670-9. PubMed ID: 27149575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of methods for estimating the number of true null hypotheses in multiplicity testing.
    Hsueh HM; Chen JJ; Kodell RL
    J Biopharm Stat; 2003 Nov; 13(4):675-89. PubMed ID: 14584715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles.
    Euceda LR; Haukaas TH; Bathen TF; Giskeødegård GF
    Methods Mol Biol; 2018; 1711():167-189. PubMed ID: 29344890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics.
    Blaise BJ; Shintu L; Elena B; Emsley L; Dumas ME; Toulhoat P
    Anal Chem; 2009 Aug; 81(15):6242-51. PubMed ID: 19585975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resampling-based empirical Bayes multiple testing procedures for controlling generalized tail probability and expected value error rates: focus on the false discovery rate and simulation study.
    Dudoit S; Gilbert HN; van der Laan MJ
    Biom J; 2008 Oct; 50(5):716-44. PubMed ID: 18932138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Zhong L; Cheng F; Lu X; Duan Y; Wang X
    Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
    Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
    Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
    Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
    Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
    J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple testing in large-scale genetic studies.
    Bouaziz M; Jeanmougin M; Guedj M
    Methods Mol Biol; 2012; 888():213-33. PubMed ID: 22665284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The problem of multiple testing and solutions for genome-wide studies].
    Gyorffy B; Gyorffy A; Tulassay Z
    Orv Hetil; 2005 Mar; 146(12):559-63. PubMed ID: 15853065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of 1H-NMR-based urinary metabonomics in Fabry disease.
    Beneduci A; Cuccurullo M; Pontoni G; Chidichimo G; Capasso G
    J Nephrol; 2010; 23 Suppl 16():S213-20. PubMed ID: 21170883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
    Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
    J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-sampling strategy to improve the estimation of number of null hypotheses in FDR control under strong correlation structures.
    Lu X; Perkins DL
    BMC Bioinformatics; 2007 May; 8():157. PubMed ID: 17509157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best (but oft-forgotten) practices: the multiple problems of multiplicity-whether and how to correct for many statistical tests.
    Streiner DL
    Am J Clin Nutr; 2015 Oct; 102(4):721-8. PubMed ID: 26245806
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.